Cargando…
Sickle Cell Disease in Jordan: The Experience of a Major Referral Center
INTRODUCTION: Sickle cell disorders are the most frequently encountered hemoglobin variants in Jordan. Both alpha and beta thalassemias are also prevalent in this population. However, studies on the interaction between these hemoglobin disorders are lacking. AIM: To determine the genotypes responsib...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Medical Sciences of Bosnia and Herzegovina
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116085/ https://www.ncbi.nlm.nih.gov/pubmed/34012195 http://dx.doi.org/10.5455/medarh.2021.75.27-30 |
_version_ | 1783691317218377728 |
---|---|
author | Oudat, Raida I. Abualruz, Heba S. Al-Shiek, Nazih KH. Abu AL-Mashaqba, Eman A. AL-Hiari, Rawan A. Alsoukhni, Hala A. Hammad, Ma’mon A. Abu |
author_facet | Oudat, Raida I. Abualruz, Heba S. Al-Shiek, Nazih KH. Abu AL-Mashaqba, Eman A. AL-Hiari, Rawan A. Alsoukhni, Hala A. Hammad, Ma’mon A. Abu |
author_sort | Oudat, Raida I. |
collection | PubMed |
description | INTRODUCTION: Sickle cell disorders are the most frequently encountered hemoglobin variants in Jordan. Both alpha and beta thalassemias are also prevalent in this population. However, studies on the interaction between these hemoglobin disorders are lacking. AIM: To determine the genotypes responsible for Sickle cell disease in Jordan, by retrospectively reviewing the data from a major referral center in the country’s capital. METHODS: A total 29,712 peripheral blood samples referred and investigated for hemoglobinopathies over a 10-year period at Princess Iman Center at Amman, Jordan were retrospectively reviewed. In addition to full blood counts, high performance liquid chromatography, those who were identified with sickle cell hemoglobin were studied using polymerase chain reaction and reverse hybridization to determine the various sickle cell disease genotypes. RESULTS: Out of the (29,712) blood samples, 450 were sickle cell trait, while 216 had sickle cell disease. Of the latter: 120 were found to be cases of Sickle cell anemia (Hb SS), 66 were compound heterozygous for Sickle cell and a beta thalassemia mutation (Sickle/β-thalassemia), while 30 had concomitant alpha thalassemia (HbSS/alpha thalassemia). The most frequent genotype associated with sickle/β-thalassemia was HbS/ IVS-110 (G>A), followed by Hb S/IVS-I-6 (T>C), HbS/IVS-II-745 (C>G) and HbS/ IVS-II-1 (G>A). While the most frequent alpha genotype detected in HbSS/α-thalassemia samples was (-α(3.7)/αα) followed by (-α(3.7)/-α(3.7)). Hb SS patients had the severest hematological phenotype compared to those with sickle/β-thalassemia and sickle/ α-thalassemia. Furthermore, within the sickle/β-thalassemia subgroup the least severe hematological phenotype was encountered in HbS/IVS-1-6 (T>C), while the most severe in HbS/IVS-II-1 (G>A) genotype. CONCLUSION: The most frequent Sickle cell disease genotype in Jordanians is Sickle cell anemia (HbSS), followed by Sickle/β-thalassemia and least frequent is HbSS/alpha thalassemia. The concomitant identified thalassemia mutations were consistent with their spectrum among the Jordanian population. |
format | Online Article Text |
id | pubmed-8116085 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Academy of Medical Sciences of Bosnia and Herzegovina |
record_format | MEDLINE/PubMed |
spelling | pubmed-81160852021-05-18 Sickle Cell Disease in Jordan: The Experience of a Major Referral Center Oudat, Raida I. Abualruz, Heba S. Al-Shiek, Nazih KH. Abu AL-Mashaqba, Eman A. AL-Hiari, Rawan A. Alsoukhni, Hala A. Hammad, Ma’mon A. Abu Med Arch Original Paper INTRODUCTION: Sickle cell disorders are the most frequently encountered hemoglobin variants in Jordan. Both alpha and beta thalassemias are also prevalent in this population. However, studies on the interaction between these hemoglobin disorders are lacking. AIM: To determine the genotypes responsible for Sickle cell disease in Jordan, by retrospectively reviewing the data from a major referral center in the country’s capital. METHODS: A total 29,712 peripheral blood samples referred and investigated for hemoglobinopathies over a 10-year period at Princess Iman Center at Amman, Jordan were retrospectively reviewed. In addition to full blood counts, high performance liquid chromatography, those who were identified with sickle cell hemoglobin were studied using polymerase chain reaction and reverse hybridization to determine the various sickle cell disease genotypes. RESULTS: Out of the (29,712) blood samples, 450 were sickle cell trait, while 216 had sickle cell disease. Of the latter: 120 were found to be cases of Sickle cell anemia (Hb SS), 66 were compound heterozygous for Sickle cell and a beta thalassemia mutation (Sickle/β-thalassemia), while 30 had concomitant alpha thalassemia (HbSS/alpha thalassemia). The most frequent genotype associated with sickle/β-thalassemia was HbS/ IVS-110 (G>A), followed by Hb S/IVS-I-6 (T>C), HbS/IVS-II-745 (C>G) and HbS/ IVS-II-1 (G>A). While the most frequent alpha genotype detected in HbSS/α-thalassemia samples was (-α(3.7)/αα) followed by (-α(3.7)/-α(3.7)). Hb SS patients had the severest hematological phenotype compared to those with sickle/β-thalassemia and sickle/ α-thalassemia. Furthermore, within the sickle/β-thalassemia subgroup the least severe hematological phenotype was encountered in HbS/IVS-1-6 (T>C), while the most severe in HbS/IVS-II-1 (G>A) genotype. CONCLUSION: The most frequent Sickle cell disease genotype in Jordanians is Sickle cell anemia (HbSS), followed by Sickle/β-thalassemia and least frequent is HbSS/alpha thalassemia. The concomitant identified thalassemia mutations were consistent with their spectrum among the Jordanian population. Academy of Medical Sciences of Bosnia and Herzegovina 2021-02 /pmc/articles/PMC8116085/ /pubmed/34012195 http://dx.doi.org/10.5455/medarh.2021.75.27-30 Text en © 2021 Raida I. Oudat, Heba S. Abualruz, Nazih KH. Abu Al-Shiek, Eman A. AL-Mashaqba, Rawan A. AL-Hiari, Hala A. Alsoukhni, Ma’mon A. Abu Hammad https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Paper Oudat, Raida I. Abualruz, Heba S. Al-Shiek, Nazih KH. Abu AL-Mashaqba, Eman A. AL-Hiari, Rawan A. Alsoukhni, Hala A. Hammad, Ma’mon A. Abu Sickle Cell Disease in Jordan: The Experience of a Major Referral Center |
title | Sickle Cell Disease in Jordan: The Experience of a Major Referral Center |
title_full | Sickle Cell Disease in Jordan: The Experience of a Major Referral Center |
title_fullStr | Sickle Cell Disease in Jordan: The Experience of a Major Referral Center |
title_full_unstemmed | Sickle Cell Disease in Jordan: The Experience of a Major Referral Center |
title_short | Sickle Cell Disease in Jordan: The Experience of a Major Referral Center |
title_sort | sickle cell disease in jordan: the experience of a major referral center |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116085/ https://www.ncbi.nlm.nih.gov/pubmed/34012195 http://dx.doi.org/10.5455/medarh.2021.75.27-30 |
work_keys_str_mv | AT oudatraidai sicklecelldiseaseinjordantheexperienceofamajorreferralcenter AT abualruzhebas sicklecelldiseaseinjordantheexperienceofamajorreferralcenter AT alshieknazihkhabu sicklecelldiseaseinjordantheexperienceofamajorreferralcenter AT almashaqbaemana sicklecelldiseaseinjordantheexperienceofamajorreferralcenter AT alhiarirawana sicklecelldiseaseinjordantheexperienceofamajorreferralcenter AT alsoukhnihalaa sicklecelldiseaseinjordantheexperienceofamajorreferralcenter AT hammadmamonaabu sicklecelldiseaseinjordantheexperienceofamajorreferralcenter |